Displaying archives for Bradley Newton, Author at ALCMI - Addario Lung Cancer Medical Institute - Page 2 of 2:

Early Study Results Find High Proportion of Young Lung Cancer Patients With Targetable Mutations

Posted by Bradley Newton on September 22nd, 2015 |

The preliminary results showed that 76 percent of study subjects under 40 had druggable mutations.

Genomics of Young Lung Cancer and INHERIT Studies Accepted for Presentation at ASCO

Posted by Bradley Newton on May 13th, 2015 |

Two Addario Lung Cancer Medical Institute research studies funded in part by the Bonnie J. Addario Lung Cancer Foundation chosen for presentation at the May/June 2015 American Society of Clinical Oncology Annual Meeting

International Partnership to Address Lung Cancer Epidemic

Posted by Bradley Newton on February 10th, 2015 |

According to a recent study in the Annals of Oncology, lung cancer fatalities are set to overtake breast cancer deaths among European women for the first time this year. It is predicted lung cancer deaths for women in Europe will reach 14.24 per 100,000 of the population in 2015.